SCHEMBL29964605

SCHEMBL29964605

O=C(c1cc2c(s1)CCSC2)N1C[C@@H]2CC[C@@H](Nc3ccc(Br)nn3)[C@@H]2C1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
HPGD P15428 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
PDE2A O00408 5/20 0.31
PDE3A Q14432 4/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
NR4A1 P22736 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
ESR2 Q92731 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PDE3B Q13370 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26983409 0.86 ALDH1A1 (0.35) ALDH1A1HPGDCYP1A2CYP2C19PDE2A
SCHEMBL29964846 0.85 ALDH1A1 (0.33) ALDH1A1HPGDCYP1A2CYP2C19PDE2A
SCHEMBL26983455 0.83 HDAC6 (0.36) ALDH1A1HPGDCYP1A2CYP2C19PDE2A
SCHEMBL30762007 0.83 HDAC6 (0.36) ALDH1A1HPGDCYP1A2CYP2C19PDE2A
SCHEMBL29965050 0.81 ALDH1A1 (0.33) ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL26983425 0.80
SCHEMBL26983456 0.78 ALDH1A1 (0.34) ALDH1A1HPGDKMT2APOLBRECQL
SCHEMBL26983404 0.78 ALDH1A1 (0.40) ALDH1A1HPGDNPC1RAB9APOLB
SCHEMBL29964853 0.77 NAMPT (0.34)
SCHEMBL29964844 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600730-B2 Substituted cyclopenta[c]pyrroles as ABHD6 antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 2026-04-14 US disclosed
US-20240270755-A1 SUBSTITUTED CYCLOPENTA[c]PYRROLES AS ABHD6 ANTAGONISTS ONO PHARMACEUTICAL CO., LTD. (JP) 2024-08-15 US disclosed
EP-4317153-A1 ABHD6 ANTAGONIST ONO Pharmaceutical Co., Ltd. (JP) 2024-02-07 EP disclosed
US-20240010658-A1 ABHD6 ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2024-01-11 US disclosed
WO-2022211060-A1 ABHD6 ANTAGONIST 小野薬品工業株式会社 2022-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240010658-A1 ABHD6 ANTAGONIST ABHD6, ABHD16A, ABHD12 ALDH1A1 994/4885HPGD 2456/4885CYP1A2 4109/4885
US-20240270755-A1 SUBSTITUTED CYCLOPENTA[c]PYRROLES AS ABHD6 ANTAGONISTS ABHD6, ABHD16A, PITHD1 ALDH1A1 1199/4885HPGD 1371/4885CYP1A2 3755/4885
US-12600730-B2 Substituted cyclopenta[c]pyrroles as ABHD6 antagonists ABHD6, ABHD16A, HDHD5 ALDH1A1 548/4885HPGD 2484/4885CYP1A2 3620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.